Reviews and analyzes disease awareness campaigns sponsored by pharmaceutical companies that use self-diagnostic tools. Uses the example of premenstrual dysphoric disorder (PMDD) to discuss how the marketing of self-diagnosis can change the patient into a consumer to achieve the aims of drug companies. (Abstract only)
Latest Articles
About Us News & Articles Resources Your Health Connect With Us
© 2012 Canadian Women's Health Network.

The Canadian Women's Health Network and the Centres of Excellence for Women's Health program are financially supported by Health Canada through the Women's Health Contribution Program. The views herein do not necessarily represent the official policy of Health Canada.
